Patent application number | Description | Published |
20090069238 | ACTIVATABLE CLOSTRIDIAL TOXINS - Compositions comprising activatable recombinant neurotoxins and polypeptides derived therefrom. The invention also comprises nucleic acids encoding such polypeptides, and methods of making such polypeptides and nucleic acids. | 03-12-2009 |
20110189162 | Modified Clostridial Toxins Comprising an Integrated Protease Cleavage Site-Binding Domain - The present specification discloses modified Clostridial toxins, compositions comprising an integrated protease cleavage site-binding domain, polynucleotide molecules encoding such modified Clostridial toxins and compositions comprising di-chain forms of such modified Clostridial toxins. | 08-04-2011 |
20110287517 | Degradable Clostridial Toxins - The specification discloses Clostridial toxins or Clostridial toxin chimeras comprising an inactivation cleavage site, polynucleotide molecules encoding such toxins or chimeras, compositions comprising such toxins or chimeras, and method of producing such toxins or chimeras. | 11-24-2011 |
20120207704 | Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases - The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating a disease or disorder associated with aberrant new blood vessel formation in a mammal using such TVEMP compositions. | 08-16-2012 |
20120207733 | Treating a Disease of Hyperproliferation Using Retargeted Endopeptidases - The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer or a disease of hyperproliferation in a mammal using such TVEMP compositions. | 08-16-2012 |
20120207742 | Treatments Using PSMA Ligand Endopeptidases - The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating a prostate cancer, a benign prostatic hyperplasia, and/or neovascularization or pathological angiogenesis associated with a cancer in a mammal using such TVEMP compositions. | 08-16-2012 |
20120207743 | Inhibiting Aberrant Blood Vessel Formation Using Retargeted Endopeptidases - The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating a disease or disorder associated with aberrant new blood vessel formation in a mammal using such TVEMP compositions. | 08-16-2012 |
20120295330 | Methods Of Intracellular Conversion Of Single-Chain Proteins Into Their Di-Chain Form - The present specification discloses expression constructs comprising single-chain proteins comprising a di-chain loop region comprising an exogenous protease cleavage site and a protease that can cleave the exogenous protease cleavage site located within the di-chain loop, cell compositions comprising such expression construct, and intracellular methods of converting the single-chain protein into its di-chain form. | 11-22-2012 |
20130195838 | Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases - The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions. | 08-01-2013 |
20130196414 | DEGRADABLE CLOSTRIDIAL TOXINS - The specification discloses Clostridial toxins or Clostridial toxin chimeras comprising an inactivation cleavage site, polynucleotide molecules encoding such toxins or chimeras, compositions comprising such toxins or chimeras, and method of producing such toxins or chimeras. | 08-01-2013 |
20130224178 | Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopepidases - The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions. | 08-29-2013 |
20130273633 | DEGRADABLE CLOSTRIDIAL TOXINS - The specification discloses Clostridial toxins or Clostridial toxin chimeras comprising an inactivation cleavage site, polynucleotide molecules encoding such toxins or chimeras, compositions comprising such toxins or chimeras, and method of producing such toxins or chimeras. | 10-17-2013 |
20130288334 | DEGRADABLE CLOSTRIDIAL TOXINS - The specification discloses Clostridial toxins or Clostridial toxin chimeras comprising an inactivation cleavage site, polynucleotide molecules encoding such toxins or chimeras, compositions comprising such toxins or chimeras, and method of producing such toxins or chimeras. | 10-31-2013 |
20130330806 | DEGRADABLE CLOSTRIDIAL TOXINS - The specification discloses Clostridial toxins or Clostridial toxin chimeras comprising an inactivation cleavage site, polynucleotide molecules encoding such toxins or chimeras, compositions comprising such toxins or chimeras, and method of producing such toxins or chimeras. | 12-12-2013 |
20130330807 | DEGRADABLE CLOSTRIDIAL TOXINS - The specification discloses Clostridial toxins or Clostridial toxin chimeras comprising an inactivation cleavage site, polynucleotide molecules encoding such toxins or chimeras, compositions comprising such toxins or chimeras, and method of producing such toxins or chimeras. | 12-12-2013 |
20140030759 | Methods Of Intracellular Conversion Of Single-Chain Proteins Into Their Di-Chain Form - The present specification discloses expression constructs comprising single-chain proteins comprising a di-chain loop region comprising an exogenous protease cleavage site and a protease that can cleave the exogenous protease cleavage site located within the di-chain loop, cell compositions comprising such expression construct, and intracellular methods of converting the single-chain protein into its di-chain form. | 01-30-2014 |
20140127783 | Degradable Clostridial Toxins - The specification discloses Clostridial toxins or Clostridial toxin chimeras comprising an inactivation cleavage site, polynucleotide molecules encoding such toxins or chimeras, compositions comprising such toxins or chimeras, and method of producing such toxins or chimeras. | 05-08-2014 |
20140127784 | MODIFIED CLOSTRIDIAL TOXINS COMPRISING AN INTEGRATED PROTEASE CLEAVAGE SITE-BINDING DOMAIN - The present specification discloses modified Clostridial toxins, compositions comprising an integrated protease cleavage site-binding domain, polynucleotide molecules encoding such modified Clostridial toxins and compositions comprising di-chain forms of such modified Clostridial toxins. | 05-08-2014 |
20140220627 | Degradable Clostridial Toxins - The specification discloses Clostridial toxins or Clostridial toxin chimeras comprising an inactivation cleavage site, polynucleotide molecules encoding such toxins or chimeras, compositions comprising such toxins or chimeras, and method of producing such toxins or chimeras. | 08-07-2014 |
Patent application number | Description | Published |
20130179224 | METHOD AND APPARATUS FOR GENERATING AND CONVERTING SALES OPPORTUNITIES - Implementations of the present disclosure involve a system and/or method of displaying and reviewing prospective customers. The system and/or method may display a prospect map showing geographic areas, corresponding technical infrastructure, and prospects present in the areas. The prospect displayed may be adjusted based on user defined prospect attributes. | 07-11-2013 |
20130179225 | METHOD AND APPARATUS FOR GENERATING AND CONVERTING SALES OPPORTUNITIES - Implementations of the present disclosure involve a system and/or method of sales prospect and customer service optimization. The system and/or method may include a computing device which operates a plurality of computing modules. These modules include a prospect module for displaying a geographic map along with technical infrastructure information and prospect information, a present module displaying a plurality of content associated with rich content, by providing an interface allowing a user to drag and drop content into a presentation flow; and a quote module for quickly creating a quote for presentation to a customer. | 07-11-2013 |
20130179790 | METHOD AND APPARATUS FOR GENERATING AND CONVERTING SALES OPPORTUNITIES - Implementations of the present disclosure involve a system and/or method of creating a presentation. The system and/or method is configured to take basic user input about a customer and a subject and automatically generate a title slide and select appropriate assets for inclusion in a presentation in order to provide the user with an easy to use system for adding content to the presentation. The system automatically populates an asset board with presentation assets associated with the customer and the subject selected. A user may then select from the assets board, which presentation assets to include in the presentation and in which order. | 07-11-2013 |
20150025940 | SYSTEMS AND METHODS FOR GENERATING CUSTOMER SOLUTIONS - Implementations described and claimed herein provide systems and methods for generating customer solutions using real-time information for new customer sales and/or current customer support. In one implementation, technical infrastructure information for an installed network design providing one or more telecommunication products at one or more customer sites is retrieved. Customer service analytics are generated based on the technical infrastructure information and output for display on a graphical user interface. | 01-22-2015 |
20150026073 | SYSTEMS AND METHODS FOR GENERATING CUSTOMER SOLUTIONS - Implementations described and claimed herein provide systems and methods for generating customer solutions using real-time information for new customer sales and/or current customer support. In one implementation, technical infrastructure data for a provider network is retrieved from one or more databases. The technical infrastructure data represents network assets and capabilities. Location information is obtained for at least one customer site. A product selection including a set of design attributes for one or more telecommunication products is received. A network access point for providing the one or more telecommunication products is determined based on a correlation of the technical infrastructure data with the location information. A configuration for the at least one customer site is generated based on the product selection. A design is generated based on the network access point and the at least one configured customer site. | 01-22-2015 |
Patent application number | Description | Published |
20110027946 | Horizontal Coffee-Stain Method Using Control Structure To Pattern Self-Organized Line Structures - A modified coffee-stain method for producing self-organized line structures and other very fine features that involves disposing a solution puddle on a target substrate, and then controlling the peripheral boundary shape of the puddle using a control structure that contacts the puddle's upper surface. The solution is made up of a fine particle solute dispersed in a liquid solvent wets and becomes pinned to both the target substrate and the control structure. The solvent is then caused to evaporate at a predetermined rate such that a portion of the solute forms a self-organized “coffee-stain” line structure on the target substrate surface that is contacted by the peripheral puddle boundary. The target structure is optionally periodically raised to generate parallel lines that are subsequently processed to form, e.g., TFTs for large-area electronic devices. | 02-03-2011 |
20110095272 | Organic Memory Array With Ferroelectric Field-Effect Transistor Pixels - An organic non-volatile memory array including multiple pixels and associated signal lines that are disposed on and between a substrate, a single ferroelectric dielectric layer, and a single organic dielectric layer, where each pixel includes a ferroelectric field-effect transistor (FeFET) and at least one organic thin-film field effect transistor (FET) that are connected to associated signal lines in a way that facilitates addressable reading and writing to the FeFET of a selected pixel without disturbing the data stored in adjacent pixels. Analog data storage in the FeFET array is also introduced that does not require analog-to-digital conversion of the stored data. | 04-28-2011 |
20110147742 | Thin Film Field Effect Transistor with Dual Semiconductor Layers - A thin film field effect transistor is disclosed which provides improved time-based channel stability. The field effect transistor includes first and second disordered semiconductor layers separated by an insulator. In an embodiment a carrier injection terminal is provided in a thin semiconductor layer closest to the gate terminal. An electric field is established in the thin semiconductor layer. At sufficient field strength, the electric field extends into the second semiconductor layer, which is in contact with the source and drain terminals. At sufficient field strength a channel is established in the second semiconductor layer, permitting current to flow between source and drain terminals. Above a certain gate voltage, there is sufficient free charge is induced in the first semiconductor layer so that the field does not extend into the second semiconductor, effectively shutting off current between source and drain. Single-device transition detection (as well as other applications) may be obtained. | 06-23-2011 |
20110309415 | SENSOR USING FERROELECTRIC FIELD-EFFECT TRANSISTOR - An embodiment is a method and apparatus to sense strain or pressure. A ferroelectric field effect transistor (feFET) structure has a semiconductor layer and a ferroelectric dielectric layer. The feFET structure is capable of sensing strain or pressure. | 12-22-2011 |
20120007079 | Thin Film Field Effect Transistor with Dual Semiconductor Layers - A thin film field effect transistor is disclosed which provides improved time-based channel stability. The field effect transistor includes first and second disordered semiconductor layers separated by an insulator. In an embodiment a carrier injection terminal is provided in a thin semiconductor layer closest to the gate terminal. An electric field is established in the thin semiconductor layer. At sufficient field strength, the electric field extends into the second semiconductor layer, which is in contact with the source and drain terminals. At sufficient field strength a channel is established in the second semiconductor layer, permitting current to flow between source and drain terminals. Above a certain gate voltage, there is sufficient free charge is induced in the first semiconductor layer so that the field does not extend into the second semiconductor, effectively shutting off current between source and drain. Single-device transition detection (as well as other applications) may be obtained. | 01-12-2012 |
20120175616 | Thin Film Field Effect Transistor with Dual Semiconductor Layers - A thin film field effect transistor is disclosed which provides improved time-based channel stability. The field effect transistor includes first and second disordered semiconductor layers separated by an insulator. In an embodiment a carrier injection terminal is provided in a thin semiconductor layer closest to the gate terminal. An electric field is established in the thin semiconductor layer. At sufficient field strength, the electric field extends into the second semiconductor layer, which is in contact with the source and drain terminals. At sufficient field strength a channel is established in the second semiconductor layer, permitting current to flow between source and drain terminals. Above a certain gate voltage, there is sufficient free charge is induced in the first semiconductor layer so that the field does not extend into the second semiconductor, effectively shutting off current between source and drain. Single-device transition detection (as well as other applications) may be obtained. | 07-12-2012 |